Long-term β-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart

European Journal of Heart Failure

Volumn 9, Issue 11, 2007, Pages 1077-1080

  El Armouche, Ali ^a   Gocht, Fabian ^a   Jaeckel, Elmar ^b   Wittköpper, Katrin ^a   Peeck, Micha ^a   Eschenhagen, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Beta adrenergic signalling; Phosphatase inhibitor 1; Phospholamban

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM; ISOPRENALINE; MESSENGER RNA; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BODY SIZE; BODY WEIGHT; CALCIUM TRANSPORT; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; HEART FAILURE; HEART MUSCLE CELL; HEART SIZE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SYMPATHETIC TONE;

ADRENERGIC BETA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CALCIUM; DOWN-REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOPROTERENOL; MALE; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 35448981911     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.09.006     Document Type: Article

References (18)

1. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307 (1982) 205-211
2. Lohse M.J., Engelhardt S., and Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?. Circ Res 93 (2003) 896-906
3. Herzig S., and Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 80 (2000) 173-210
4. Oliver C.J., and Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front Biosci 3 (1998) D961-D972
5. El-Armouche A., Rau T., Zolk O., Ditz D., Pamminger T., Zimmermann W.H., et al. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. Faseb J 17 (2003) 437-439
6. Carr A.N., Schmidt A.G., Suzuki Y., del Monte F., Sato Y., Lanner C., et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 22 (2002) 4124-4135
7. Braz J.C., Gregory K., Pathak A., Zhao W., Sahin B., Klevitsky R., et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10 (2004) 248-254
8. Pathak A., del Monte F., Zhao W., Schultz J.E., Lorenz J.N., Bodi I., et al. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res 96 (2005) 756-766
9. El-Armouche A., Pamminger T., Ditz D., Zolk O., and Eschenhagen T. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc Res 61 (2004) 87-93
10. Neumann J., Eschenhagen T., Jones L.R., Linck B., Schmitz W., Scholz H., et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 29 (1997) 265-272
11. El-Armouche A., Jaeckel E., Boheler K.R., Boknik P., Hertle B., Neumann J., et al. Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts. Biochem Biophys Res Commun 318 (2004) 219-226
12. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77 (1988) 721-730
13. Boluyt M.O., Long X., Eschenhagen T., Mende U., Schmitz W., Crow M.T., et al. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol 269 (1995) H638-H647
14. Boknik P., Fockenbrock M., Herzig S., Knapp J., Linck B., Luss H., et al. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 362 (2000) 222-231
15. MacDougall L.K., Jones L.R., and Cohen P. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 196 (1991) 725-734
16. MacLennan D.H., and Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4 (2003) 566-577
17. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37 (1998) 279-289
18. Schwinger R.H., Bohm M., Schmidt U., Karczewski P., Bavendiek U., Flesch M., et al. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92 (1995) 3220-3228